Zepbound®
US$ 20.73
semaglutide/tirzepatide/b6 Tirzepatide with B6 for weight loss with minimal side effects New Weight Loss Injection: Tirzepatide
Description
The SURMOUNT-4 trial demonstrated clearly what happens when treatment stops
About 92% of participants lost more than 10% of their body weight, and 84% lost more than 15%
Dysesthesia occurred in 22.9% of participants at the 7.2mg dose versus only 6% at the 2.4mg dose and 0.5% with placebo
doi: 10.1038/s41574-024-01047-y, 43
Each time you step up to a higher dose, you might notice a brief return of headache symptoms
Hypoglycemia is a potential concern, particularly when combined with insulin or sulfonylureas, requiring careful monitoring of blood glucose levels
